BioInnovatise, Inc.
Verified PartnerUnited States
Advanced Modalities
Regulatory, Tech Transfer & Support Services
Contract Research Organization
Company Overview
About
BioInnovatise is a US-based CDMO specializing in quick-turnaround molecular biology services for early-stage drug discovery. Services include plasmid DNA services, viral vector packaging, and CRISPR-Cas9 services. The company collaborates with researchers in government, academia, and industry, focusing on custom cloning and the early discovery phase of drug development.
Key Expertise
plasmid DNA services (molecular cloning, mutagenesis, library construction design, plasmid prep), viral vector packaging (AAV, adenovirus, lentivirus, retrovirus), CRISPR-Cas9 cell line expression services (knock-in, knock-out)
Therapeutic Areas
Infectious Disease
Oncology
Ophthalmology
Cardiovascular
Neurology & CNS
Metabolic Disease
Rare Disease
Dermatology
Immunology
Respiratory
Gastroenterology
Hematology
Women's Health / Reproductive Medicine
Nephrology
Vaccines
Regenerative Medicine
Quick Facts
HQ:United States
Founded:2008
Employees:5
Capabilities & Services
Core Capabilities
- Viral Vectors
- Analytical Services
- Method Development
Technology Platforms
Biologics Manufacturer
Cell & Gene Therapy
Containment Capabilities
BSL-2 (Biosafety Level 2)
Production Scales
R&D / Pre-clinical
Lab Scale
Batch Sizes
< 1L
Markets Served
North America
Europe
Asia Pacific
Latin America
Middle East
Africa
Manufacturing Facilities
1 site worldwide
Headquarters
13 Taft Court, Rockville, Maryland, 20850
Established 2008
Site Capabilities
Formulation Development
Process Development
Scale-up
Certifications
No certifications on file yet.
Customer Reviews
No reviews available yet.
Company Documents
No documents available.